176 related articles for article (PubMed ID: 1828420)
1. A double-blind dose-response study of amlodipine in patients with stable angina pectoris.
Cocco G; Alfiero R
Eur Heart J; 1991 Feb; 12(2):169-74. PubMed ID: 1828420
[TBL] [Abstract][Full Text] [Related]
2. Amlodipine combined with beta blockade for chronic angina: results of a multicenter, placebo-controlled, randomized double-blind study.
DiBianco R; Schoomaker FW; Singh JB; Awan NA; Bennett T; Canosa FL; Kawanishi DT; Bamrah VS; Glasser SP; Barry W
Clin Cardiol; 1992 Jul; 15(7):519-24. PubMed ID: 1354085
[TBL] [Abstract][Full Text] [Related]
3. Clinical safety and efficacy of once-a-day amlodipine for chronic stable angina pectoris.
Glasser SP; West TW
Am J Cardiol; 1988 Sep; 62(9):518-22. PubMed ID: 2970788
[TBL] [Abstract][Full Text] [Related]
4. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
Witkowska M; Tracz W; Kubler G; Negrusz-Kawecka M; Hlawaty M; Olszowska M; Salamon P
Przegl Lek; 1997; 54(5):324-8. PubMed ID: 9380807
[TBL] [Abstract][Full Text] [Related]
5. A 6-week double-blind comparison of amlodipine and placebo in patients with stable exertional angina pectoris receiving concomitant beta-blocker therapy.
Klein W; Mitrovic V; Neuss H; Schlepper M; Cocco G; Prager G; Fitscha P; Meisner W
J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S50-2. PubMed ID: 16296710
[TBL] [Abstract][Full Text] [Related]
6. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, placebo-controlled, parallel dose-response study of amlodipine in stable exertional angina pectoris.
Taylor SH; Lee P; Jackson N; Cocco G
J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S46-9. PubMed ID: 16296709
[TBL] [Abstract][Full Text] [Related]
8. Amlodipine in angina pectoris: effect on maximal and submaximal exercise performance.
Kinnard DR; Harris M; Hossack KF
J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S110-3. PubMed ID: 2467119
[TBL] [Abstract][Full Text] [Related]
9. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
Ruzyllo W; Tendera M; Ford I; Fox KM
Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
[TBL] [Abstract][Full Text] [Related]
10. Endurance testing for evaluation of antianginal therapy with amlodipine, a calcium channel blocking agent.
Kinnard DR; Harris M; Hossack KF
J Am Coll Cardiol; 1988 Sep; 12(3):791-6. PubMed ID: 2969930
[TBL] [Abstract][Full Text] [Related]
11. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
[TBL] [Abstract][Full Text] [Related]
12. [Amlodipine versus nifedipine retard. A randomized double-blind comparative study on long-term efficacy and safety of amlodipine and nifedipine retard in the monotherapy of chronic stable angina pectoris].
Sauerbrey-Wullkopf N; Kupper W
Herz; 2001 Mar; 26(2):149-56. PubMed ID: 11349617
[TBL] [Abstract][Full Text] [Related]
13. An 8-week double-blind study of amlodipine and diltiazem in patients with stable exertional angina pectoris.
Bernink PJ; de Weerd P; ten CF; Remme WJ; Barth J; Enthoven R; Haagen FD; Holwerda NJ; Klomps HC
J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S53-6. PubMed ID: 16296711
[TBL] [Abstract][Full Text] [Related]
14. A four-week double-blind, placebo-controlled, parallel dose-response study of amlodipine in patients with stable exertional angina pectoris.
Taylor SH; Lee P; Jackson N; Cocco G
Am Heart J; 1989 Nov; 118(5 Pt 2):1133-4. PubMed ID: 2530875
[No Abstract] [Full Text] [Related]
15. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
[TBL] [Abstract][Full Text] [Related]
16. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of amlodipine in myocardial ischemia.
Taylor SH
Am Heart J; 1989 Nov; 118(5 Pt 2):1123-6. PubMed ID: 2573266
[TBL] [Abstract][Full Text] [Related]
18. The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group.
Fox KM; Mulcahy D; Findlay I; Ford I; Dargie HJ
Eur Heart J; 1996 Jan; 17(1):96-103. PubMed ID: 8682138
[TBL] [Abstract][Full Text] [Related]
19. A review of amlodipine in myocardial ischaemia.
Taylor SH
Postgrad Med J; 1991; 67 Suppl 5():S48-51. PubMed ID: 1839440
[TBL] [Abstract][Full Text] [Related]
20. Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. The Zatebradine Study Group.
Frishman WH; Pepine CJ; Weiss RJ; Baiker WM
J Am Coll Cardiol; 1995 Aug; 26(2):305-12. PubMed ID: 7608428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
